Tocilizumab, a Novel Monoclonal Antibody Targeting IL-6 Signaling, Significantly Reduces Disease Activity in Patients with Rheumatoid Arthritis

Article Information

DOI 
http://dx.doi.org/10.1177/155989770700700404
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2007 MD Conference Express

Author Information

  1. Maria Vinall
  1. Josef S. Smolen, MD
    1. Medical University of Vienna, Center of Rheumatic Diseases at Hietzing Hospital, Vienna, Austria
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015400
Jul 2015011
Aug 2015100
Sep 2015100
Oct 2015132
Nov 2015232
Total1475

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Tocilizumab, a Novel Monoclonal Antibody Targeting IL-6 Signaling, Significantly Reduces Disease Activity in Patients with Rheumatoid Arthritis
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.